Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Recruiting
N/A
Interventional Study
Perimenopause
PMDD
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 55
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Texas Christian University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
PMS/PMDD Study:
Inclusion Criteria:
* Assigned female at birth
* Age 18 to 45
* Naturally cycling
* Regularly occurring menstrual cycle
* Must identify as having PMS or PMDD
* Reliable ability to complete online study surveys
Exclusion Criteria:
* Using hormonal birth control
* Pregnant or lacta…
Contacts